Biological mechanisms of resilience to tau pathology in Alzheimer's disease.

IF 7.9 1区 医学 Q1 CLINICAL NEUROLOGY
Anna L Svenningsson, Diana I Bocancea, Erik Stomrud, Anita van Loenhoud, Frederik Barkhof, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele
{"title":"Biological mechanisms of resilience to tau pathology in Alzheimer's disease.","authors":"Anna L Svenningsson, Diana I Bocancea, Erik Stomrud, Anita van Loenhoud, Frederik Barkhof, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele","doi":"10.1186/s13195-024-01591-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In Alzheimer's disease (AD), the associations between tau pathology and brain atrophy and cognitive decline are well established, but imperfect. We investigate whether cerebrospinal fluid (CSF) biomarkers of biological processes (vascular, synaptic, and axonal integrity, neuroinflammation, neurotrophic factors) explain the disconnection between tau pathology and brain atrophy (brain resilience), and tau pathology and cognitive decline (cognitive resilience).</p><p><strong>Methods: </strong>We included 428 amyloid positive participants (134 cognitively unimpaired (CU), 128 with mild cognitive impairment (MCI), 166 with AD dementia) from the BioFINDER-2 study. At baseline, participants underwent tau positron emission tomography (tau-PET), magnetic resonance imaging (MRI), cognitive testing, and lumbar puncture. Longitudinal data were available for MRI (mean (standard deviation) follow-up 26.4 (10.7) months) and cognition (25.2 (11.4) months). We analysed 18 pre-selected CSF proteins, reflecting vascular, synaptic, and axonal integrity, neuroinflammation, and neurotrophic factors. Stratifying by cognitive status, we performed linear mixed-effects models with cortical thickness (brain resilience) and global cognition (cognitive resilience) as dependent variables to assess whether the CSF biomarkers interacted with tau-PET levels in its effect on cortical atrophy and cognitive decline.</p><p><strong>Results: </strong>Regarding brain resilience, interaction effects were observed in AD dementia, with vascular integrity biomarkers (VEGF-A (β<sub>interaction</sub> = -0.009, p<sub>FDR</sub> = 0.047) and VEGF-B (β<sub>interaction</sub> = -0.010, p<sub>FDR</sub> = 0.037)) negatively moderating the association between tau-PET signal and atrophy. In MCI, higher NfL levels were associated with more longitudinal cortical atrophy (β = -0.109, p<sub>FDR</sub> = 0.033) and lower baseline cortical thickness (β = -0.708, p<sub>FDR</sub> = 0.033) controlling for tau-PET signal. Cognitive resilience analyses in CU revealed interactions with tau-PET signal for inflammatory (GFAP, IL-15; β<sub>interaction</sub> -0.073--0.069, p<sub>FDR</sub> 0.001-0.045), vascular (VEGF-A, VEGF-D, PGF; β<sub>interaction</sub> -0.099--0.063, p<sub>FDR</sub> < 0.001-0.046), synaptic (14-3-3ζ/δ; β<sub>interaction</sub> = -0.092, p<sub>FDR</sub> = 0.041), axonal (NfL; β<sub>interaction</sub> = -0.079, p<sub>FDR</sub> < 0.001), and neurotrophic (NGF; β<sub>interaction</sub> = 0.091, p<sub>FDR</sub> < 0.001) biomarkers. In MCI higher NfL levels (β<sub>main</sub> = -0.690, p<sub>FDR</sub> = 0.025) were associated with faster cognitive decline independent of tau-PET signal.</p><p><strong>Conclusions: </strong>Biomarkers of co-existing pathological processes, in particular vascular pathology and axonal degeneration, interact with levels of tau pathology on its association with the downstream effects of AD pathology (i.e. brain atrophy and cognitive decline). This indicates that vascular pathology and axonal degeneration could impact brain and cognitive resilience.</p>","PeriodicalId":7516,"journal":{"name":"Alzheimer's Research & Therapy","volume":null,"pages":null},"PeriodicalIF":7.9000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470552/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's Research & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13195-024-01591-9","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In Alzheimer's disease (AD), the associations between tau pathology and brain atrophy and cognitive decline are well established, but imperfect. We investigate whether cerebrospinal fluid (CSF) biomarkers of biological processes (vascular, synaptic, and axonal integrity, neuroinflammation, neurotrophic factors) explain the disconnection between tau pathology and brain atrophy (brain resilience), and tau pathology and cognitive decline (cognitive resilience).

Methods: We included 428 amyloid positive participants (134 cognitively unimpaired (CU), 128 with mild cognitive impairment (MCI), 166 with AD dementia) from the BioFINDER-2 study. At baseline, participants underwent tau positron emission tomography (tau-PET), magnetic resonance imaging (MRI), cognitive testing, and lumbar puncture. Longitudinal data were available for MRI (mean (standard deviation) follow-up 26.4 (10.7) months) and cognition (25.2 (11.4) months). We analysed 18 pre-selected CSF proteins, reflecting vascular, synaptic, and axonal integrity, neuroinflammation, and neurotrophic factors. Stratifying by cognitive status, we performed linear mixed-effects models with cortical thickness (brain resilience) and global cognition (cognitive resilience) as dependent variables to assess whether the CSF biomarkers interacted with tau-PET levels in its effect on cortical atrophy and cognitive decline.

Results: Regarding brain resilience, interaction effects were observed in AD dementia, with vascular integrity biomarkers (VEGF-A (βinteraction = -0.009, pFDR = 0.047) and VEGF-B (βinteraction = -0.010, pFDR = 0.037)) negatively moderating the association between tau-PET signal and atrophy. In MCI, higher NfL levels were associated with more longitudinal cortical atrophy (β = -0.109, pFDR = 0.033) and lower baseline cortical thickness (β = -0.708, pFDR = 0.033) controlling for tau-PET signal. Cognitive resilience analyses in CU revealed interactions with tau-PET signal for inflammatory (GFAP, IL-15; βinteraction -0.073--0.069, pFDR 0.001-0.045), vascular (VEGF-A, VEGF-D, PGF; βinteraction -0.099--0.063, pFDR < 0.001-0.046), synaptic (14-3-3ζ/δ; βinteraction = -0.092, pFDR = 0.041), axonal (NfL; βinteraction = -0.079, pFDR < 0.001), and neurotrophic (NGF; βinteraction = 0.091, pFDR < 0.001) biomarkers. In MCI higher NfL levels (βmain = -0.690, pFDR = 0.025) were associated with faster cognitive decline independent of tau-PET signal.

Conclusions: Biomarkers of co-existing pathological processes, in particular vascular pathology and axonal degeneration, interact with levels of tau pathology on its association with the downstream effects of AD pathology (i.e. brain atrophy and cognitive decline). This indicates that vascular pathology and axonal degeneration could impact brain and cognitive resilience.

阿尔茨海默氏症中 tau 病理学复原的生物机制。
背景:在阿尔茨海默病(AD)中,tau病理变化与脑萎缩和认知能力下降之间的联系已被证实,但并不完善。我们研究了脑脊液(CSF)生物标志物(血管、突触和轴突完整性、神经炎症、神经营养因子)是否能解释tau病理与脑萎缩(脑恢复力)、tau病理与认知能力下降(认知恢复力)之间的脱节:我们纳入了BioFINDER-2研究的428名淀粉样蛋白阳性参与者(134名认知功能未受损者(CU)、128名轻度认知功能受损者(MCI)、166名AD痴呆症患者)。在基线期,参与者接受了tau正电子发射断层扫描(tau-PET)、磁共振成像(MRI)、认知测试和腰椎穿刺。磁共振成像(平均(标准差)随访 26.4 (10.7) 个月)和认知(25.2 (11.4) 个月)的纵向数据均已获得。我们分析了 18 种预先选择的 CSF 蛋白,它们反映了血管、突触和轴突的完整性、神经炎症和神经营养因子。根据认知状况进行分层,我们建立了以皮质厚度(脑恢复力)和整体认知(认知恢复力)为因变量的线性混合效应模型,以评估 CSF 生物标志物与 tau-PET 水平对皮质萎缩和认知能力下降的影响是否相互影响:在脑恢复力方面,AD痴呆症中观察到了交互效应,血管完整性生物标志物(VEGF-A(β交互作用=-0.009,pFDR=0.047)和VEGF-B(β交互作用=-0.010,pFDR=0.037))对tau-PET信号和萎缩之间的关联有负向调节作用。在 MCI 中,较高的 NfL 水平与更多的纵向皮质萎缩(β = -0.109,pFDR = 0.033)和较低的基线皮质厚度(β = -0.708,pFDR = 0.033)相关,但与 tau-PET 信号无关。对 CU 的认知恢复力分析表明,炎症(GFAP、IL-15;β交互作用 -0.073--0.069,pFDR 0.001-0.045)、血管(VEGF-A、VEGF-D、PGF;β交互作用 -0.099--0.063,pFDR 交互作用 = -0.092,pFDR = 0.041)、轴突(NfL;β交互作用 = -0.079,pFDR交互作用 = 0.091,pFDR主 = -0.690,pFDR = 0.025)与认知能力下降速度加快相关,与tau-PET信号无关:结论:并存病理过程的生物标志物,尤其是血管病理和轴突变性,与tau病理水平相互作用,对AD病理的下游效应(即脑萎缩和认知能力下降)产生影响。这表明血管病理学和轴突变性可能会影响大脑和认知的恢复能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy 医学-神经病学
CiteScore
13.10
自引率
3.30%
发文量
172
审稿时长
>12 weeks
期刊介绍: Alzheimer's Research & Therapy is an international peer-reviewed journal that focuses on translational research into Alzheimer's disease and other neurodegenerative diseases. It publishes open-access basic research, clinical trials, drug discovery and development studies, and epidemiologic studies. The journal also includes reviews, viewpoints, commentaries, debates, and reports. All articles published in Alzheimer's Research & Therapy are included in several reputable databases such as CAS, Current contents, DOAJ, Embase, Journal Citation Reports/Science Edition, MEDLINE, PubMed, PubMed Central, Science Citation Index Expanded (Web of Science) and Scopus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信